succinobucol has been researched along with 1,1-diphenyl-2-picrylhydrazyl in 1 studies
Studies (succinobucol) | Trials (succinobucol) | Recent Studies (post-2010) (succinobucol) | Studies (1,1-diphenyl-2-picrylhydrazyl) | Trials (1,1-diphenyl-2-picrylhydrazyl) | Recent Studies (post-2010) (1,1-diphenyl-2-picrylhydrazyl) |
---|---|---|---|---|---|
53 | 5 | 16 | 5,375 | 15 | 3,471 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buřičová, L; Drašar, P; Galandáková, A; Horníček, J; Ikonen, S; Jurček, O; Kolehmainen, ET; Ulrichová, J; Wimmer, Z; Wimmerová, M | 1 |
1 other study(ies) available for succinobucol and 1,1-diphenyl-2-picrylhydrazyl
Article | Year |
---|---|
Succinobucol's new coat--conjugation with steroids to alter its drug effect and bioavailability.
Topics: 3T3 Cells; Animals; Anti-Inflammatory Agents; Antioxidants; Biological Availability; Biphenyl Compounds; Clinical Trials as Topic; Fibroblasts; Free Radicals; Humans; Mice; Mice, Inbred BALB C; Molecular Structure; Picrates; Probucol; Static Electricity; Steroids | 2011 |